Evaluating Opportunities to Improve Healthcare Delivery and Outcomes Part 2: The Impact of Mindfulness and Compassion on Patient Perceptions of Care
April 30, 2020
April 30, 2021
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Postgraduate Institute for Medicine and CE Health Interactive.
Supported by an independent educational grant from Pfizer.
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
All other health care professionals completing this course will be issued a statement of participation.
This activity is intended for healthcare providers (physicians, allied healthcare professionals) who are on the front-lines of patient care and directly manage patients on a daily basis.
The overarching goal of this innovative initiative is to address healthcare provider knowledge and practice gaps as they relate to the delivery of optimal care from the aspects of the patient/provider relationship, communication, and mindfulness. These fundamental factors of the clinical encounter can have a significant impact on perceptions of care, patient satisfaction, and subsequent health management and outcomes. As such, this program will provide a dynamic educational initiative for practicing healthcare providers on the rationale for, and real-world, practice-based strategies to, improve communication and collaboration with patients, including awareness of mindfulness, and interpersonal interactions.
Upon completion of this activity, participants should be better able to:
- Examine the relationship between empathy, mindfulness, and compassion
- Evaluate the potential impact of mindfulness and compassion on patient perceptions of care and, subsequently, health outcomes
- Discuss evidence-based approaches to improving mindfulness for both healthcare providers and their patients
- Identify opportunities to improve mindfulness, and the delivery of compassionate care, in the practice setting
Damaris Maria Grossman, DNP, FNP
Integrative Family Nurse Practitioner
Doctor of Nurse Practice
Kathryn Mclaughlin, BSN, RN
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and CE Health Interactive. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflicts of Interest
The faculty have nothing to disclose
Planners and Managers
The PIM planners and managers have nothing to disclose. The CE Health Interactive planners and manager have nothing to disclose.
Instructions for Participation and Credit
During the period April 30, 2020, through April 30, 2021, participants must 1) read the learning objectives and disclosures; 2) study the educational activity; and 3) complete the post-test and the evaluation form. To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click on Submit Post-test at the bottom of the page. Your post-test will automatically be graded. If you successfully complete the post-test (score of 75% or higher), your certificate will be made available immediately. Click on View Certificate and print the certificate for your records. If you receive a score of 74% or less, you will receive a message notifying you that you did not pass the post-test. You may retake the post-test until successful.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities